Trial NCT01218867

View at ClinicalTrials.gov 
Org. Study IDs: 110013
Secondary IDs: 11-C-0013

Last trial update was posted on 2019-12-10

MeSH Interventions

Aldesleukin Cyclophosphamide Fludarabine

MeSH Conditions

Kidney Neoplasms Melanoma Neoplasm Metastasis Neoplasms Neoplasms, Second Primary

Other Conditions

Metastatic Cancer Metastatic Melanoma Renal Cancer

Stopping Reasons

No objective responses were observed.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID